Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease. Brummer C, Evert K, Keil F, Schmidt J, et al. Ann Hematol 2026;105:18.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brummer C, Evert K, Keil F, Schmidt J, et al. Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease. Ann Hematol 2026;105:18.
PMID: 41535617